Ipsen SA (IPN)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

€120.00

Buy

€120.60

arrow-down€-0.50 (-0.41%)

Prices updated at 17 Dec 2025, 16:35 CET
| Prices minimum 15 mins delay
|
Prices in EUR
Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.
FTSE EuroFirst 300
arrow-down-0.03%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

1.400
Cash Dividend
04 Jun 2025
13 Feb 2025
05 Jun 2025
06 Jun 2025

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20251.4000-
20241.2000-
20231.2000-
20221.20000.20
20211.0000-
20201.0000-
20191.0000-
20181.00000.18
20170.8500-
20160.8500-

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20251.130.33
20241.08-
20231.110.22
20221.190.45
20211.240.55
20201.470.35
20191.270.23
20180.890.07
20170.850.07
20161.240.29

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20251.4000
20241.2000
20231.2000
20221.2000
20211.0000
20201.0000
20191.0000
20181.0000
20170.8500
20160.8500

% of earnings paid to shareholders data table

YearPayout ratio (%)
202526.07
202415.09
202324.54
202213.56
202113.35
2020-
201920.58
201824.21
201732.44
201630.25
Latest Financial Report as of 16 Dec 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.